Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma.
Jianguo WangJianyong ZhuoYaoye TaoShengjun XuZun ChenFan YangQinghong KeHaiyang XieShusen ZhengHangxiang WangXiao XuPublished in: International journal of nanomedicine (2020)
Our results show that SAL-based nanoprodrugs are a promising platform for treating patients with HCC and a novel strategy for combination therapy of cancers.